Lerbs, Tristan - assoc. RG 69

We investigate how transcriptional programs and membrane-associated signaling pathways regulate tumor progression and response to therapy. A particular focus lies on the transcription factor SIX1 and the tetraspanin CD63, with the goal of identifying and preclinically validating novel therapeutic strategies.

For further information, please visit the Lerbs Lab. 

• Center for Molecular Medicine Cologne
• Dept. of Pathology, University Hospital of Cologne